They support the pharmaceutical, biotech, and medtech industries by conducting drug trials and other activities to develop and refine the latest drugs and devices.
Their growing presence is most visible in the field of medical oncology, where many compounds that have the potential to treat CRO cancer are currently being tested on human subjects.
Cost efficiency is one of the key benefits of
CRO. It allows companies to streamline their operations and lower their overhead. Contract research organizations can also help pharmaceutical companies bring new medicines to the market quicker.
Nick Lucas, Senior Vice President of Professional Services at Medidata Solutions, explains how outsourcing can benefit both companies.
The global CRO services market is segmented into five regions. The North America region accounted for the largest share of the CRO services market in 2016.
This is primarily due to adherence to pharmaceutical industry standards, the growth of biosimilars, and the brisk growth of clinical trial operations in this region.
Comments